1[1]Lok AS.Natural history and control of perinatally acquired hepatitis B virus infection.Dig Dis 1992; 10:46-52
2[2]Chisari FV,Ferrari C.Hepatitis B virus immunopathogenesis.Annu Rev Immunol 1995; 13:29-60
3[3]Chisari FV,Ferrari C.Hepatitis B virus immunopathology.Springer Semin Immunopathol 1995; 17:261-281
4[4]Missale G,Bertoni R,Lamonaca V,Valli A,Massari M,Mori C,Rumi MG,Houghton M,Fiaccadori F,Ferrari C..Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the antiviral cell-mediated immune response.J Clin Invest 1996; 98:706-714
5[5]Zheng X,Weinberger KM,Gehrke R,Isogawa M,Hilken G,Kemper T,Xu Y,Yang D,Jilg W,Roggendorf M,Lu M.Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity.Virology 2004; 329:454-464
6[6]Swenson PD,Escobar MR,Carithers RL Jr,Sobieski TJ 3rd.Failure of preexisting antibody against hepatitis B surface antigen to prevent subsequent hepatitis B infection.J Clin Microbiol 1983; 18:305-309
7[7]Chen YC,Delbrook K,Dealwis C,Mimms L,Mushahwar IK,Mandecki W.Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library.Proc Natl Acad Sci USA 1996; 93:1997-2001
8[8]Torresi J.The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus.J Clin Virol 2002; 25:97-106
9[9]Ogura Y,Kurosaki M,Asahina Y,Enomoto N,Marumo F,Sato C.Prevalence and significance of naturally occurring mutations in the surface and polymerase genes of hepatitis B virus.J Infect Dis 1999; 180:1444-1451
10[10]Tai PC,Banik D,Lin Gl,Pai S,Pai K,Lin MH,Yuoh G,Che S,Hsu SH,Chen TC,Kuo TT,Lee CS,Yang CS,Shih C.Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class Ⅰ-restricted T-cell epitope of the surface antigen.J Virol 1997; 71:4852-4856
2Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
7KALYANDA S,XIONG XF,YANG HL,et al. Molecular modeling and bicohemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC)[J]. Virology, 2001,75 (10) :4771-4779.
8SIMON A,DAVE B,CHONG GT,et al. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the light cycler [J]. Clin Micr biol,2001,39(4): 1456-1459.
9WRIGHT TL. Chronic hepatitis B infection [J]. Am J Gastroententerol, 2006, 101 Suppl 1 : S 1-6.
10WATANABE K,TAKAHASHI T,TAKAHASHI S.Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations[J]. J Gastroenterol Hepatol, 2005,20 : 441- 449.
